AIM: Accumulating data show that patients with bipolar disorder (BD) experience substantial symptomatology months or years before full manifestation. Based on the need for early preventive interventions in BD as well as data suggesting effectiveness of psychotherapeutic interventions for BD, we aimed to review the evidence for psychotherapeutic treatments in help-seeking individuals considered at risk for BD (At-Risk-BD). METHODS: Searching PubMed and PsycINFO, clinical trial registries and recently published systematic reviews, a systematic review was performed of psychoeducational and psychotherapeutic intervention studies in At-Risk-BD individuals. RESULTS: Only three completed studies were identified, two of which were randomized trials (n = 77) and one was an open pilot study (n = 13). Two ongoing studies (projected n = 150 and n = 100, respectively) were found in trial registries. The available evidence suggests potential effectiveness of multi-family psychoeducational psychotherapy and family-focussed therapy for symptom reduction and prevention of BD conversion. CONCLUSIONS: Psychotherapeutic treatments are a reasonable starting point for At-Risk-BD subjects when symptom severity, distress and impairment are sufficiently significant to initiate treatment. Ongoing studies will further clarify the effectiveness and timing of psychotherapeutic interventions for At-Risk-BD individuals and whether or not they should be given alone or in conjunction with other treatments. Large multi-site studies with standardized procedures/manuals are needed to advance the field.
AIM: Accumulating data show that patients with bipolar disorder (BD) experience substantial symptomatology months or years before full manifestation. Based on the need for early preventive interventions in BD as well as data suggesting effectiveness of psychotherapeutic interventions for BD, we aimed to review the evidence for psychotherapeutic treatments in help-seeking individuals considered at risk for BD (At-Risk-BD). METHODS: Searching PubMed and PsycINFO, clinical trial registries and recently published systematic reviews, a systematic review was performed of psychoeducational and psychotherapeutic intervention studies in At-Risk-BD individuals. RESULTS: Only three completed studies were identified, two of which were randomized trials (n = 77) and one was an open pilot study (n = 13). Two ongoing studies (projected n = 150 and n = 100, respectively) were found in trial registries. The available evidence suggests potential effectiveness of multi-family psychoeducational psychotherapy and family-focussed therapy for symptom reduction and prevention of BD conversion. CONCLUSIONS: Psychotherapeutic treatments are a reasonable starting point for At-Risk-BD subjects when symptom severity, distress and impairment are sufficiently significant to initiate treatment. Ongoing studies will further clarify the effectiveness and timing of psychotherapeutic interventions for At-Risk-BD individuals and whether or not they should be given alone or in conjunction with other treatments. Large multi-site studies with standardized procedures/manuals are needed to advance the field.
Authors: K Leopold; A Nikolaides; M Bauer; A Bechdolf; C U Correll; F Jessen; G Juckel; A Karow; M Lambert; J Klosterkötter; S Ruhrmann; S Pfeiffer; A Pfennig Journal: Nervenarzt Date: 2015-03 Impact factor: 1.214
Authors: Elif M Sikoglu; Ana A Liso Navarro; Debra Starr; Yael Dvir; Benjamin Udoka Nwosu; Suzanne M Czerniak; Ryan C Rogan; Martha C Castro; Richard A E Edden; Jean A Frazier; Constance M Moore Journal: J Child Adolesc Psychopharmacol Date: 2015-06 Impact factor: 2.576
Authors: Martine Vallarino; Chantal Henry; Bruno Etain; Lillian J Gehue; Craig Macneil; Elizabeth M Scott; Angelo Barbato; Philippe Conus; Stefanie A Hlastala; Mary Fristad; David J Miklowitz; Jan Scott Journal: Lancet Psychiatry Date: 2015-05-27 Impact factor: 27.083
Authors: Gonzalo Salazar de Pablo; Daniel Guinart; Barbara A Cornblatt; Andrea M Auther; Ricardo E Carrión; Maren Carbon; Sara Jiménez-Fernández; Ditte L Vernal; Susanne Walitza; Miriam Gerstenberg; Riccardo Saba; Nella Lo Cascio; Martina Brandizzi; Celso Arango; Carmen Moreno; Anna Van Meter; Christoph U Correll Journal: J Child Adolesc Psychopharmacol Date: 2020-02-21 Impact factor: 2.576
Authors: Anna R Van Meter; Danella M Hafeman; John Merranko; Eric A Youngstrom; Boris B Birmaher; Mary A Fristad; Sarah M Horwitz; L Eugene Arnold; Robert L Findling Journal: J Am Acad Child Adolesc Psychiatry Date: 2020-10-08 Impact factor: 13.113
Authors: Andrea Pfennig; Karolina Leopold; Andreas Bechdolf; Christoph U Correll; Martin Holtmann; Martin Lambert; Carolin Marx; Thomas D Meyer; Steffi Pfeiffer; Andreas Reif; Maren Rottmann-Wolf; Natalie M Schmitt; Thomas Stamm; Georg Juckel; Michael Bauer Journal: Trials Date: 2014-05-08 Impact factor: 2.279